Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,205.50
-0.80 (-0.04%)
At close: Dec 5, 2025
Mankind Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Market Capitalization | 910,339 | 1,000,400 | 921,654 | - | - | - | Upgrade
|
| Market Cap Growth | -12.54% | 8.54% | - | - | - | - | Upgrade
|
| Enterprise Value | 961,467 | 960,198 | 902,241 | - | - | - | Upgrade
|
| Last Close Price | 2205.50 | 2423.79 | 2299.84 | - | - | - | Upgrade
|
| PE Ratio | 51.81 | 50.25 | 48.18 | - | - | - | Upgrade
|
| Forward PE | 39.31 | 45.13 | 43.88 | - | - | - | Upgrade
|
| PS Ratio | 6.72 | 8.20 | 8.98 | - | - | - | Upgrade
|
| PB Ratio | 5.86 | 6.87 | 9.63 | - | - | - | Upgrade
|
| P/TBV Ratio | - | - | 12.00 | - | - | - | Upgrade
|
| P/FCF Ratio | 38.69 | 51.24 | 50.17 | - | - | - | Upgrade
|
| P/OCF Ratio | 31.68 | 41.45 | 42.82 | - | - | - | Upgrade
|
| PEG Ratio | 2.39 | 2.64 | 1.91 | - | - | - | Upgrade
|
| EV/Sales Ratio | 7.10 | 7.87 | 8.79 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 29.57 | 32.12 | 35.87 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 39.56 | 39.89 | 41.96 | - | - | - | Upgrade
|
| EV/FCF Ratio | 40.87 | 49.18 | 49.11 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.54 | 0.58 | 0.02 | 0.02 | 0.14 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 2.58 | 2.84 | 0.08 | 0.09 | 0.44 | 0.16 | Upgrade
|
| Debt / FCF Ratio | 3.56 | 4.36 | 0.11 | 0.17 | 1.94 | 0.34 | Upgrade
|
| Asset Turnover | 0.63 | 0.62 | 0.95 | 0.93 | 1.00 | 1.09 | Upgrade
|
| Inventory Turnover | 2.24 | 2.01 | 2.17 | 1.84 | 1.69 | 1.77 | Upgrade
|
| Quick Ratio | 0.76 | 0.73 | 2.05 | 1.14 | 0.65 | 1.78 | Upgrade
|
| Current Ratio | 1.14 | 1.23 | 3.10 | 2.32 | 1.68 | 2.89 | Upgrade
|
| Return on Equity (ROE) | 13.46% | 16.62% | 22.57% | 18.79% | 25.99% | 30.30% | Upgrade
|
| Return on Assets (ROA) | 7.07% | 7.58% | 12.40% | 10.53% | 14.76% | 17.37% | Upgrade
|
| Return on Capital (ROIC) | 8.60% | 9.16% | 15.29% | 13.24% | 18.56% | 22.22% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.10% | 10.90% | 21.80% | 20.20% | 28.10% | 31.70% | Upgrade
|
| Earnings Yield | 1.92% | 1.99% | 2.08% | - | - | - | Upgrade
|
| FCF Yield | 2.58% | 1.95% | 1.99% | - | - | - | Upgrade
|
| Payout Ratio | 2.36% | - | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -2.35% | -0.88% | -0.14% | -0.00% | - | - | Upgrade
|
| Total Shareholder Return | -2.25% | -0.88% | -0.14% | -0.00% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.